Articles From: BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses to LSB Industries, Inc. Reports Downtime at Cherokee Plant


RESEARCH TRIANGLE PARK, N.C., Dec.
Sign-up for BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses investment picks
NEW YORK, Dec.
Sign-up for Semi-Annual Changes to the NASDAQ OMX ABA Community Bank Index investment picks
Conference call to be held at 9:00 a.m. EST on Monday, December 15th PARAMUS, New Jersey , December 15, 2014 /PRNewswire/ -- Ceragon Networks Ltd.
Sign-up for Ceragon Takes Action Intended to Accelerate Its Return to Profitability investment picks
Honeywell (HON) on Monday trimmed its fourth-quarter sales outlook and provided 2015 guidance that was below expectations, although its profit forecast was mostly in line with analyst estimates.
Sign-up for Honeywell's 2015 sales outlook is below expectations, but profit seen in line investment picks
NEW YORK, Dec.
Sign-up for Annual Changes to the NASDAQ Biotechnology Index investment picks
By David Benoit and Dana Mattioli Largest private-equity buyout of the year PetSmart Inc. (PETM) has agreed to be bought by a group led by BC Partners Inc. for more than $8.2 billion, the largest private-equity buyout in an otherwise lackluster year for such deals.
Sign-up for PetSmart to be bought by BC Partners for about $8.2 billion investment picks
2014/12/15
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks rose Monday, moving toward their first advance in six sessions, as recently beaten-down oil shares posted modest advances.
Sign-up for UPDATE: FTSE 100 gains on respite for oil shares investment picks
NEW YORK, Dec.
Sign-up for Quarterly Changes to the NASDAQ Golden Dragon China Index investment picks
CF101 is currently one of the few Oral Drugs developed for Glaucoma A US Patent for the utilization of CF101 for Glaucoma Treatment will be Valid until 2030 The Glaucoma Market Size is estimated to be approximately $3B PETACH TIKVA, Israel , Dec.
Sign-up for Second Part of the Glaucoma Phase II study has been Approved in a European Country investment picks
Chesapeake Energy Corporation (NYSE:CHK) today announced that its Board of Directors has declared a $0.0875 per share quarterly dividend that will be paid on January 31, 2015 to common shareholders of record on January 15, 2015.
Sign-up for Chesapeake Energy Corporation Declares Quarterly Common and Preferred Stock Dividends investment picks
Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that the first patient has been enrolled in a Phase 3 clinical trial of dalfampridine for the treatment of post-stroke walking deficits (PSWD). “Approximately three and a half million stroke survivors in the U.S. suffer ongoing mobility issues.
Sign-up for Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits investment picks
bebe stores, inc.
Sign-up for Jim Wiggett Named Chief Executive Officer of bebe stores, inc. investment picks
Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has entered into an incremental joinder to increase the available credit capacity from $750 million to $900 million under its senior secured asset-based revolving credit facility (the “ABL Facility”). The increase in the borrowing capacity will be effective upon completion of the Company’s merger with Gentiva Health Services, Inc. (“Gentiva”), which is expected in the first quarter of 2015.
Sign-up for Kindred Healthcare Expands Borrowing Capacity under Its Revolving Credit Agreement by $150 Million investment picks
2014/12/15
The Kentucky Board of Pharmacy has released an enhanced site built with responsive framework, streamlined content and more prominent calls to action for users.
Sign-up for Kentucky Board of Pharmacy Releases an Enhanced Site investment picks
MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatal, anesthesia, maternal-fetal, pediatric cardiology, and other pediatric physician services, today announced the commencement of a $200 million accelerated share repurchase (ASR) program with JPMorgan Chase Bank, N.A. Under the terms of the ASR, MEDNAX will repurchase $200 million of its common stock, with an aggregate initial delivery of approximately 2.5 million shares.
Sign-up for MEDNAX Commences $200 Million Accelerated Share Repurchase Program investment picks
At the Sixth AFM BioMed Conference, Bruker (NASDAQ: BRKR) today announced the release of BioScope Resolve™ , a biological atomic force microscope (bioAFM) that features the highest resolution imaging and most complete cell mechanics capabilities available for use with an inverted optical microscope (IOM). The system incorporates Bruker’s proprietary PeakForce Tapping® technology to enable researchers to achieve both the highest resolution imaging and piconewton level force measurements on biological samples.
Sign-up for Bruker Introduces BioScope Resolve High-Resolution BioAFM System investment picks
Dicerna Pharmaceuticals, Inc .
Sign-up for Dicerna R&D Update Webcast Reminder investment picks
Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced that it has entered into an amendment to its license agreement with Nerviano Medical Sciences, S.r.l. relating to its entrectinib (formerly RXDX-101) product candidate.
Sign-up for Ignyta Announces Amendment to License Agreement with Nerviano investment picks
2014/12/15
- Almost all holiday shoppers surveyed (93%) have had to purchase a last-minute gift at some point - Nearly 7 in 10 holiday shoppers surveyed would rather do their last-minute shopping in a store than online - Last-minute shoppers cite indecision (43%) as the leading cause for having to purchase gifts in the 11th hour AUSTIN, Texas , Dec.
Sign-up for Panic Saturday! More Than Half of Christmas Shoppers Typically Have Not Completed Their Holiday Shopping by the Saturday Before Christmas investment picks
- Transformational Acquisition Broadens Portfolio and Strengthens Global Footprint - Accretive to Earnings and Margins in 2015 BELOIT, Wis.
Sign-up for Regal Beloit Corporation to Acquire Emerson's Power Transmission Solutions Business investment picks
2014/12/15
In 2014 Ritchie Bros.
Sign-up for Ritchie Bros. sells CA$73+ million of equipment in final Edmonton auction of the year investment picks
Alkermes plc (NASDAQ: ALKS) today announced the initiation of a phase 1 clinical study of extended dosing intervals of aripiprazole lauroxil, the company’s investigational, novel, long-acting injectable atypical antipsychotic for the treatment of schizophrenia.
Sign-up for Alkermes Announces Initiation of Clinical Study of Extended Durations of Aripiprazole Lauroxil for Treatment of Schizophrenia investment picks
2014/12/15
ROSH HAAYIN, Israel , December 15, 2014 /PRNewswire/ -- In accordance with Section 318(b) of the Israeli Companies Law, 5769-1999 (the " Companies Law ") and Regulation 3 of the Israeli Companies Regulations (Merger), 5770-2000, Pointer Telocation Ltd.
Sign-up for Pointer Telocation - Notice of Merger with Shagrir Systems Ltd. investment picks
AVENTURA, Fla., Dec.
Sign-up for Trade Street Residential Announces Dividend for the Fourth Quarter of 2014 investment picks
YAHUD, Israel , December 15, 2014 /PRNewswire/ -- Magal Security Systems, Ltd.
Sign-up for Magal is Awarded $2.1 Million Contract for an Integrated Security Solution for the Port of Tarragona in Spain investment picks
Insmed Incorporated (Nasdaq:INSM) today provides a regulatory and clinical update on the Company’s development programs.
Sign-up for Insmed Provides End of Year Regulatory and Clinical Update investment picks
Company Also Reaffirms 2014 Earnings Outlook Of $5.50-$5.55 - Company Forecasts 2015 Organic Sales Growth Of ~4%, Up 1%-2% Reported - 2015 Earnings Growth Driven By Sales Growth And Operational Performance - 4Q $0.14 BEAV Share Gain Funds Aerospace OEM Incentives - Net $0 Impact - On Track To Achieving 2018 Long-Term Targets MORRIS TOWNSHIP, N.J. , Dec.
Sign-up for Honeywell Forecasts 2015 Sales Of $40.5-$41.1 Billion, Proforma Earnings Per Share Of $5.95-$6.15, Up 8%-12% investment picks
Brian L.
Sign-up for Franklin C. West to Retire Effective January 1, 2015 investment picks
LSB Industries, Inc. (NYSE:LXU) (“LSB or the Company”) today announced that its chemical plant facility in Cherokee, Alabama (“Cherokee Facility”) was taken out of service in late November 2014 for unplanned maintenance related to the replacement of a bearing in the facility’s ammonia plant, and a subsequent gasket leak and damage to insulation material which occurred upon start-up of the plant.
Sign-up for LSB Industries, Inc. Reports Downtime at Cherokee Plant investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses to LSB Industries, Inc. Reports Downtime at Cherokee Plant
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent